1-8 of 8
Sirpa Leppa, MD Prof
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutational Dynamics and Evolutionary Divergence in DLBCL: A Call for Relapse Sampling

Jillian F. Wise, PhD, Sigve Nakken, PhD, Chloé B Steen, PhD, Daniel Vodák, BS, Gunhild Trøen, Bjarne Johannessen, PhD, Ole Christian Lingjærde, PhD, Vera Hilden, Yngvild Nuvin Blaker, MD PhD, Baoyan Bai, PhD, Lars B. Aasheim, Annika Pasanen, MD PhD, Suzanne Lorenz, PhD, Anita Sveen, PhD, Ragnhild Lothe, PhD, Ola Myklebost, PhD, Sirpa Leppa, MD Prof, Leonardo Meza-Zepeda, PhD, Klaus Beiske, MD PhD, Michael S. Lawrence, PhD, Eivind Hovig, PhD, June Helen Myklebust, PhD, Erlend B. Smeland, MD PhD, Harald Holte, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1497.
https://doi.org/10.1182/blood-2019-131072
Published: 2019
Journal Articles

Genomic Profiling of Circulating Tumor DNA Reveals Patterns of Response and Refractoriness in Aggressive B-Cell Lymphoma - a Nordic Lymphoma Group Correlative Study

Leo Meriranta, MD, Amjad Alkodsi, PhD, Annika Pasanen, MD PhD, Maija Lepistö, MSc, Yngvild Nuvin Blaker, MD PhD, Matias Autio, Judit Jørgensen, MD PhD, Mats Jerkeman, MD Professor, Harald Holte, MD PhD, Pekka Ellonen, BSc, Sirpa Leppa, MD Prof
Journal: Blood
Blood (2019) 134 (Supplement_1): 1481.
https://doi.org/10.1182/blood-2019-132168
Published: 2019
Journal Articles

Molecular Background of Double Protein Expressor B-Cell Lymphomas

Leo Meriranta, MD, Amjad Alkodsi, PhD, Annika Pasanen, MD PhD, Jari Haukka, PhD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Sirpa Leppa, MD Prof
Journal: Blood
Blood (2019) 134 (Supplement_1): 2781.
https://doi.org/10.1182/blood-2019-131220
Published: 2019
Journal Articles

Immunogenomic Landscape of Hematological Malignancies

Olli Dufva, Petri Pölönen, MSc, Oscar Brück, MD, Mikko A Keränen, MD PhD, Juha Mehtonen, MSc, Sanna M. Siitonen, MD PhD, Suvi-Katri Leivonen, PhD, Leo Meriranta, MS, Sirpa Leppa, MD Prof, Matti Nykter, Olli Lohi, MD PhD, Merja Heinäniemi, PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2596.
https://doi.org/10.1182/blood-2018-99-118335
Published: 2018
Journal Articles

Outcomes for Patients with High-Risk Relapsed or Refractory Indolent B-Cell Lymphoma Treated with Copanlisib in the CHRONOS-1 Study

Armando Santoro, MD, Luigina Mollica, MD PhD, Sirpa Leppa, MD Prof, George A Follows, MD PhD, Georg Lenz, Won Seog Kim, MD PhD, Arnon Nagler, MD, Maria Dimou, MD PhD, Judit Demeter, MD PhD Dr. Sci, Massimo Magagnoli, MD, Liana Rodrigues, MD, Oliver Wirtz, MSc, Florian Hiemeyer, MSc, Li Liu, PhD, Karl Koechert, PhD, Jose Garcia-Vargas, MD, Barrett H Childs, MD, Pier Luigi Zinzani, MD, Martin H. Dreyling, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 395.
https://doi.org/10.1182/blood-2018-99-116715
Published: 2018
Journal Articles

B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso(lo)Ne) in Older Patients with Advanced-Stage Hodgkin Lymphoma: Results of a Phase II Intergroup Trial By the German Hodgkin Study Group (GHSG) and the Nordic Lymphoma Group (NLG)

Boris Boell, MD, Alexander Fosså, MD PhD, Helen Goergen, Peter Kamper, Sirpa Leppa, MD Prof, Daniel Molin, Julia Meissner, MD, Ellen Ritter, MD, Jacob H. Christensen, Martin Hutchings, MD, Michael Fuchs, Andreas Engert, MD, Carsten Kobe, MD, Peter Borchmann, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 926.
https://doi.org/10.1182/blood-2018-99-119363
Published: 2018
Journal Articles

Clinical and Biological Features behind Hallmark Aberrations in Diffuse Large B-Cell Lymphoma

Leo Meriranta, MS, Annika Pasanen, MD PhD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Sandeep Dave, MD, Sirpa Leppa, MD Prof
Journal: Blood
Blood (2018) 132 (Supplement 1): 2976.
https://doi.org/10.1182/blood-2018-99-117958
Published: 2018
Journal Articles

Young High Risk Patients with MYC/BCL2 Double Hit Lymphoma, BCL2+ and/or Germinal Centre B-Cell like Diffuse Large B-Cell Lymphoma Benefit from Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis: Analysis of Data from the Nordic Lymphoma Group CRY-04 and Chic Trials

Sirpa Leppa, MD Prof, Judit Jørgensen, MD PhD, Leo Meriranta, MS, Klaus Beiske, MD PhD, Jan M.A. Delabie, MD PhD, Elisabeth Ralfkiaer, MD DMSC, Signe Spetalen, MD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Harald Holte, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2955.
https://doi.org/10.1182/blood-2018-99-120057
Published: 2018